Medscape Compared with patients with no exposure to SGAs, the investigators also noted increased risk associated with use of aripiprazole (HR, 2.92; 95% CI, 1.08 - 7.90) or ziprasidone (HR, 3.56; 95% CI, 1.61 - 7.89). Mood stabilizers also increased risk (HR, 1 ...
MedPage Today After adjustment for sociodemographics and substance use disorders, risks were 20% to 30% lower with any use of aripiprazole (Abilify), quetiapine (Seroq...
Psychiatric News ... June 6 that Abilify ( aripiprazole ) has received an additional approval from Health Canada as an adjunct treatment for major depressive disorder (MDD) in adults who had an inadequate response to prior antidepressant treatments during the current ...
Monthly Prescribing Reference In contrast, aripiprazole (which has been considered metabolically sparing) had no effect on postprandial hormones but also induced insulin resistance. The changes occurred without weight gain, increase in food intake and hunger, or psychiatric disease. and more »
MarketWatch In addition to the three newly unveiled drug candidates, the company will provide details on its later-stage pipeline candidates, specifically: commercial pl...
4-traders (press release) Tokyo Japan - Otsuka Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo, Japan; President and Representative Director, CEO: Tatsuo Higuchi, "Otsuka Holdings") announces 2013 second quarter U.S. net sales*1 figures of ABILIFY ( aripiprazole ), the ...
PharmaTimes Meanwhile, NICE has also issued final guidance recommending Otsuka's Abilify ( aripiprazole ) as an option for treating moderate to severe manic episodes in ...
Clinical Psychiatry News Digital Network The i-FANS study was a multicenter, open-label trial involving 500 adults with schizophrenia randomized to a gradual or immediate switch from risperidone (Risperdal), olanzapine (Zyprexa), or aripiprazole (Abilify) to iloperidone (Fanapt). The switch ...
